Sade Biotech is excited to introduce our new head nurse – Jenny Arieli
Sade Biotech is excited to introduce our new head nurse, Jenny Arieli, as head of the ASAYA Patient Support Program. We are happy to share
Blog
Our Updates
Sade Biotech pioneers the accessibility of medical cannabis treatment for Alzheimer’s and Dementia patients
In January 2022, the Ministry of Health in Israel approved the use of medical cannabis to treat Dementia and Alzheimer’s in the adult population. Sade
Sadé Biotech And Its ASAYA™ Software Can now be Marketed in Europe
Excited to share with you that our ASAYA system was successfully registered with the Belgian Federal Agency for Medicines and Health Products and it is
Sade Biotech Enters Exciting Collaboration with Leading Israeli Rehabilitation Center
At Sade, we’re always looking for new ways to collect, analyze, and harness collective wisdom on everything medical cannabis (MC), in order to provide the
Sade Biotech Welcomes New Team Member Itzik Hamo
Sade Biotech is on a mission to harness the power of collective wisdom to transform medical cannabis care. To achieve this goal, the leading scientific
New ASAYA PSP Head Naama Saban-Ohana to Integrate Cannabis Experience with Patient-Centric Support
Sade Group welcomes our newest recruit, Naama Saban-Ohana, with open arms, A certified nurse and former Head of Training & Education and VP Customer Services
The Upside of Covid-19: More Individualized Medical Cannabis Care
The Covid-19 pandemic has driven widespread adoption of digital data and technology across all sectors and industries, including medical cannabis, so as to provide higher
Big Data Analysis to Improve Medical Cannabis Patient Care
When used in the healthcare context, the term “Real-World Data” (RWD) usually refers to patient-level data gathered outside the conventional clinical trial setting. Such data
MORE CONTENT ON IT'S WAY
SUBSCRIBE & ENJOY
WE DO NOT SEND SPAM – ONLY UPDATES & NEWS